OPTH.US Optimi Health Corp. Common Shares

Healthcare Pharmaceuticals USA Stocks
2.25 USD
Close of Nov 15, 2026
1.90 8.84
Market cap
USD 12.9M
P/E
-
P/B
1.04x
ROE
-51.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is OPTH.US undervalued?

Graham number

The Graham number of Optimi Health Corp. Common Shares cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Optimi Health Corp. Common Shares fundamental analysis

No fundamental analysis for Optimi Health Corp. Common Shares yet.

Optimi Health Corp. Common Shares stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Optimi Health Corp. Common Shares

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness mar…

Full company profile